Understanding and responding to methamphetamine use

Crystalline methamphetamine, or ice, is a significant and growing public health concern in Australia. This research aims to improve our understanding of the epidemiology of methamphetamine use, particularly with a view to guiding public health responses, and develop new and innovative ways to treat methamphetamine dependence and respond to the health risks associated with use.

Name & Contact Details Role Location

Arunogiri, S. and McKetin, R. (2019). Comment on Zang et al 2019: Distinguishing between psychotic and general psychiatric symptoms in the context of methamphetamine use. Addiction Biology. DOI: 10.1111/adb.12776 [RJ1486] View web page

Cartwright, K. and Tait, R., J. (2019). Service providers’ experience of methamphetamine and the portrayal of the ‘ice epidemic’ in remote Australia. Australian Journal of Rural Health, 27, (1), pp. 83-87. DOI: 10.1111/ajr.12483 [RJ1378] View web page

McKetin, R., Dean, O., Turner, A., Kelly, P., Quinn, B., Lubman, D., Dietze, P., Carter, G., Higgs, P., Baker, A., Sinclair, B., Reid, D., Manning, V., te Pas, N., Liang, W., Thomas, T., Bathish, R., Kent, M., Raftery, D., Arunogiri, S. and Berk, M. (2019). A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (ice) dependence. Trials, 20, (1). DOI: 10.1186/s13063-019-3450-0 [RJ1485] View web page

McKetin, R., Voce, A., Burns, R., A. and Shanahan, M. (2019). Health-related quality of life among people who use methamphetamine. Drug and Alcohol Review, 38, (5), pp. 503-509. DOI: 10.1111/dar.12934 [RJ1481] View web page

Voce, A., Burns, R., A., Castle, D., Calabria, B. and McKetin, R. (2019). Is there a discrete negative symptom syndrome in people who use methamphetamine? Comprehensive Psychiatry, 93, pp. 27-32. DOI: 10.1016/j.comppsych.2019.06.002 [RJ1515] View web page

Voce, A., McKetin, R., Calabria, B., Burns, R., A. and Castle, D. (2019). A systematic review of the symptom profile and course of methamphetamine-associated psychosis: Substance use and misuse. Substance Use and Misuse, 54, (4), pp. 549-559. DOI: 10.1080/10826084.2018.1521430 [RJ1445] View web page

Arunogiri, S., Foulds, J., McKetin, R. and Lubman, D. (2018). A systematic review of risk factors for methamphetamine-associated psychosis. Australian and New Zealand Journal of Psychiatry. DOI: 10.1177/0004867417748750 [RJ1390] View web page

Ezard, N., Dunlop, A., McKetin, R., Bruno, R., Ali, R., L., Carr, A., White, J., Clifford, B., Hall, M., Liu, Z., Shanahan, M., Dolan, K. and Lintzeris, N. (2018). LiMA: a study protocol for a randomised, double blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. BMJ Open. DOI: 10.1136/bmjopen-2017-020723 [RJ1438] View web page

McKetin, R. (2018). Methamphetamine psychosis: insights from the past. Addiction, 113, (5), pp. 1522-1527. DOI: 10.1111/add.14170 [RJ1417] View web page

McKetin, R., Degenhardt, L., Shanahan, M., Baker, A., L., Lee, N. and Lubman, D. (2018). Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact. Drug and Alcohol Review, 37, (2), pp. 196-204. DOI: 10.1111/dar.12518 [RJ1296] View web page

McKetin, R., Hides, L., Kavanagh, D., Saunders, J., B. and Dawe, S. (2018). First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine (Letter to the Editor). Schizophrenia Research. DOI: 10.1016/j.schres.2018.04.021 [RJ1420] View web page

McKetin, R., Kothe, A., Baker, A., Lee, N., Ross, J. and Lubman, D. (2018). Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study (MATES). Drug and Alcohol Review, 37, (1), pp. 70-78. DOI: 10.1111/dar.12528 [RJ1289] View web page

McKetin, R., Voce, A., Burns, R., A., Ali, R., L., Lubman, D., Baker, A. and Castle, D. (2018). Latent psychotic symptom profiles amongst people who use methamphetamine: What do they tell us about existing diagnostic categories? Frontiers in Psychiatry. DOI: 10.3389/fpsyt.2018.00578 [RJ1468] View web page

Tait, R., J., Whetton, S., Shanahan, M., Cartwright, K., Ferrante, A., Gray, D., Kaye, S., McKetin, R., Pidd, K., Ritter, A., Roche, A. and Allsop, S. (2018). Quantifying the societal cost of methamphetamine use to Australia. International Journal of Drug Policy, 62, pp. 30-36. DOI: 10.1016/j.drugpo.2018.08.015 [RJ1452] View web page

Degenhardt, L., Sara, G., McKetin, R., Roxburgh, A., Dobbins, T., Farrell, M., Burns, L. and Hall, W. (2017). Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review, 36, (2), pp. 160-170. DOI: 10.1111/dar.12426 [RJ1231] View web page

McKetin, R., Baker, A., Dawe, S., Voce, A. and Lubman, D. (2017). Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. Psychiatry Research, 251, pp. 349–354. DOI: 10.1016/j.psychres.2017.02.028 [RJ1310] View web page

McKetin, R., Dean, O., Baker, A., Carter, G., Turner, A., Kelly, P. and Berk, M. (2017). A potential role for N-acetylcysteine in the management of methamphetamine dependence. Drug and Alcohol Review, 36, (2), pp. 153–159. DOI: 10.1111/dar.12414 [RJ1236] View web page

McKetin, R., Voce, A. and Burns, R., A. (2017). Research into methamphetamine use in the Australian Capital Territory. National Drug Research Institute, Curtin University, Perth, Western Australia. ISBN: 978-0-9942806-6-4 [R313] Download PDF

Whetton, S., Shanahan, M., Cartwright, K., Duraisingam, V., Ferrante, A., Gray, D., Kaye, S., Kostadinov, V., McKetin, R., Pidd, K., Roche, A., Tait, R., J. and Allsop, S. (2017). The Social Costs of Methamphetamine in Australia 2013/14. In Tait, R., J. (ed.). National Drug Research Institute, Curtin University, Perth, Western Australia. ISBN: 978-0-9942806-0-2 [T246] Download PDF

Degenhardt, L., Larney, S., Chan, G., Dobbins, T., Weier, M., Roxburgh, A., Hall, W. and McKetin, R. (2016). Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014. Medical Journal of Australia, 204, (4), pp. 153. DOI: 10.5694/mja15.00671 [RJ1239] View web page

McKetin, R., Degenhardt, L. and Hall, W. (2016). Estimating the number of regular and dependent methamphetamine users in Australia, 2002–2014: Response to Dietze and colleagues. Medical Journal of Australia, 205, (9), pp. 426. DOI: 10.5694/mja16.01043 [RJ1271] View web page

McKetin, R., Gardner, J., Baker, A., Dawe, S., Ali, R., L., Voce, A., Leach, L. and Lubman, D. (2016). Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry Research, 238, pp. 166-171. DOI: 10.1016/j.psychres.2016.02.038 [RJ1237] View web page

McKetin, R., Parasu, P., Cherbuin, N., Eramudugolla, R. and Anstey, K., J. (2016). A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults. Drug and Alcohol Dependence, 169, pp. 134-140. DOI: 10.1016/j.drugalcdep.2016.10.022 [RJ1270] View web page